España
Acceder
  1. Inicio
  2. Perfil de Knikord
  3. Participaciones

Participaciones del usuario Knikord

Knikord 11/03/23 15:58
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
GP Vaccination Market to Witness Massive Growth by Novavax, BioNTech, Modernahttps://www.newstrail.com/gp-vaccination-market-to-witness-massive-growth-by-novavax-biontech-moderna/Porca miseria!..
Ir a respuesta
Knikord 18/01/23 14:17
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
 Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult BoosterJan 18, 2023GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Nuvaxovid™ (NVX-CoV2373) for use as a booster for active immunization to prevent COVID-19 in adults aged 18 and older. Prior to the approval, in September 2022, the Korean Centers for Disease Control and Prevention set out recommendations that advised that Nuvaxovid could be used as a booster in adults aged 18 and older."We are pleased to collaborate with SK bioscience to offer our protein-based vaccine, Nuvaxovid, for use as a booster in adults regardless of previous vaccine history," said Stanley C. Erck, President and Chief Executive Officer, Novavax. "This is an important step in ensuring broad access to diversified vaccine options." https://ir.novavax.com/2023-01-18-Novavax-Nuvaxovid-COVID-19-Vaccine-Approved-in-South-Korea-as-an-Adult-Booster
Ir a respuesta
Knikord 14/01/23 07:22
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
In January 2020, at the beginning of the pandemic, the company was "down to 100 people, down to $100M market cap, and down to enough money to get through May that year," Erck said.Today, the company boasts a commercial product that is approved in 47 countries in the past year, roughly 2,000 employees, over $1 billion in the bank, and ened 2022 with a record $2 billion revenue from year one of sales.https://nz.finance.yahoo.com/news/outgoing-novavax-ceo-the-government-has-to-get-out-of-the-way-194311386.htmlY con la misma cotización que entonces?. Hay algo que no cuadra…
Ir a respuesta
Knikord 16/12/22 22:06
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
!!!Que espectáculo!!!En dos días, se han intercambiado la práctica totalidad de los títulos de la compañía, algo más. Supongo que es una parte de ellos en modo noria entre los grandes manipuladores del mercado. Esto deja claro, por si no lo estaba, que el business, el gran business está en los derivados. El subyacente, es secundario, es el mamporrero y puede esperar. Yo derivados, ni olerlos, me provocan náusea.Pues nada, aprovechamos la coyuntura en la medida de lo posible y nos armaremos de paciencia.
Ir a respuesta